An acute reversible experimental model of pneumonia in pigs: time‐related histological and clinical signs changes |
| |
| Authors: | N VILLARINO D GARCIA‐TAPIA S LESMAN M LUCAS J ROBINSON S A BROWN T MARTIN‐JIMENEZ |
| |
| Institution: | 1. Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA;2. Pfizer Animal Health, Kalamazoo, MI, USA |
| |
| Abstract: | The objective of this study was to evaluate the long‐term survival rates, clinical response, and lung gross and microscopic changes in pigs treated intratracheally with lipopolysaccharide of Escherichia coli 0111:B4 (LPS‐Ec). Healthy pigs were randomly allocated to three groups: (i) no‐LPS‐Ec (n = 1), (ii) LPS‐Ec‐T1 (1 mg/mL, 10 mL/pig) (n = 7), and (iii) LPS‐Ec‐T2 (0.5 mg/mL, 10 mL/pig) (n = 6). Two pigs from each dose group were euthanized at 24 (n = 3 for T1), 48 and 144 h post‐LPS‐Ec challenge. LPS‐Ec‐treated animals showed macroscopic lesions in middle lobes of the lung. A reversible recruitment of macrophages and neutrophils was observed at 24, 48, and 144 h post‐LPS‐Ec challenge. The highest cellular infiltration level was observed at 24 h after challenge. The highest clinical scores were evident in both experimental dose levels within 3 and 5 h after LPS‐Ec administration. Administration of LPS‐Ec, under the conditions evaluated, can be used to induce a reproducible model of acute pulmonary inflammation in pigs. |
| |
| Keywords: | |
|
|
